financetom
Business
financetom
/
Business
/
Japan's Rigaku aims to raise up to $888 mln in IPO, term sheet says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Japan's Rigaku aims to raise up to $888 mln in IPO, term sheet says
Sep 20, 2024 6:51 AM

HONG KONG, Sept 20 (Reuters) - Japan's Rigaku, which

makes X-ray testing tools, is aiming to raise up to $888 million

in its initial public offering in Tokyo, according to a term

sheet reviewed by Reuters.

Rigaku, owned by private equity firm Carlye Group, is

eyeing a market value of $2 billion after the offering, the term

sheet said.

Rigaku is planning to start bookbuilding on Oct. 10 and

debut on Oct. 25, the term sheet said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chartwell Raises $345 Million in Trust Unit Offering
Chartwell Raises $345 Million in Trust Unit Offering
Jun 27, 2024
10:20 AM EDT, 06/27/2024 (MT Newswires) -- Chartwell Retirement Residences (CSH-UN.TO) said Thursday that it raised $345 million after closing a public offering of more than 28 million trust units priced at $12.20 apiece. The company said it plans to use the proceeds to partially finance the cash purchase price on its acquisition of a portfolio of five retirement residences...
Factbox-US banks weather Fed's annual stress test, but risks rise
Factbox-US banks weather Fed's annual stress test, but risks rise
Jun 27, 2024
(Reuters) - Big U.S. banks had enough capital to weather a potentially severe economic downturn but some of their risky businesses could hypothetically take a major hit this year, according to results of the Federal Reserve's annual stress test. The 31 banks that participated showed they could withstand a spike in joblessness and stresses in the commercial real estate market...
KalVista Starts Hereditary Angioedema Trial in Pediatric Patients
KalVista Starts Hereditary Angioedema Trial in Pediatric Patients
Jun 27, 2024
10:18 AM EDT, 06/27/2024 (MT Newswires) -- KalVista Pharmaceuticals ( KALV ) said Thursday it has initiated a clinical trial of sebetralstat in hereditary angioedema patients. The study will enroll about 24 children aged two to 11 in seven countries in North America, Europe and Asia, KalVista said. The company said the trial will collect safety, pharmacokinetic and efficacy data...
FIFA working with UBS to raise up to $2 billion, Bloomberg News reports
FIFA working with UBS to raise up to $2 billion, Bloomberg News reports
Jun 27, 2024
June 27 (Reuters) - Soccer governing body FIFA is seeking to raise up to $2 billion to expand its streaming service and a formal process is expected to kick off next month, Bloomberg News reported on Thursday. The international body is working with UBS Group AG for the fund-raise that is expected to target financial investors in the U.S. and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved